Sherise D. Ferguson, M.D.

Peer-Reviewed Articles

1. Glitza Oliva IC, Ferguson SD, Bassett R, Foster AP, John I, Hennegan TD, Rohlfs M, Richard J, Iqbal M, Dett T, Lacey C, Jackson N, Rodgers T, Phillips S, Duncan S, Haydu L, Lin R, Amaria RN, Wong MK, Diab A, Yee C, Patel SP, McQuade JL, Fischer GM, McCutcheon IE, O'Brien BJ, Tummala S, Debnam M, Guha-Thakurta N, Wargo JA, Carapeto FCL, Hudgens CW, Huse JT, Tetzlaff MT, Burton EM, Tawbi HA, Davies MA. Author Correction: Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results. Nat Med. e-Pub 2024. PMID: 38649781.
2. Huntoon KM, Gasco J, Glitza Oliva IC, Ferguson SD, Majd NK, McCutcheon IE. Ventriculoperitoneal shunting with an on-off valve for patients with leptomeningeal metastases and intracranial hypertension. Neurooncol Pract 11(1):56-63, 2024. e-Pub 2023. PMID: 38222058.
3. Haider AS, McCutcheon IE, Ene CI, Fuller GN, Schomer DF, Gule-Monroe M, DeMonte F, Ferguson SD, Lang FF, Prabhu SS, Raza SM, Suki D, Weinberg JS, Sawaya R. Subependymomas of the fourth ventricle: To operate or not to operate?. J Clin Neurosci 118:147-152, 2023. e-Pub 2023. PMID: 37944358.
4. Garg AK, Hernandez M, Schlembach PJ, Bowers JR, McAleer MF, Brown PD, Gopal R, Wiederhold L, Swanson T, Shah SJ, Li J, Ferguson SD, Philip NV, DeGracia L, Bloom ES, Chun SG. A phase II clinical trial of frameless fractionated stereotactic radiotherapy for brain metastases. JNCI Cancer Spectr. e-Pub 2023. PMID: 37944053.
5. Smalley I, Boire A, Brastianos P, Kluger HM, Hernando-Monge E, Forsyth PA, Ahmed KA, Smalley KSM, Ferguson S, Davies MA, Glitza Oliva IC. Leptomeningeal disease in melanoma: An update on the developments in pathophysiology and clinical care. Pigment Cell Melanoma Res. e-Pub 2023. PMID: 37622466.
6. Hasanov M, Milton DR, Davies AB, Sirmans E, Saberian C, Posada EL, Opusunju S, Gershenwald JE, Torres-Cabala CA, Burton EM, Colen RR, Huse JT, Glitza Oliva IC, Chung C, McAleer MF, McGovern SL, Yeboa DN, Kim BYS, Prabhu SS, McCutcheon IE, Weinberg JS, Lang FF, Tawbi HA, Li J, Haydu LE, Davies MA, Ferguson SD. Changes In Outcomes And Factors Associated With Survival In Melanoma Patients With Brain Metastases. Neuro Oncol 25(7):1310-1320, 2023. e-Pub 2022. PMID: 36510640.
7. Buszek SM, Tran B, Long JP, Luo D, Suki D, Li J, Ferguson S, Chung C. Postoperative Management of Recurrence After Radiosurgery and Surgical Resection for Brain Metastases and Predicting Benefit From Adjuvant Radiation. Pract Radiat Oncol. e-Pub 2023. PMID: 37295724.
8. Glitza Oliva IC, Ferguson SD, Bassett R, Foster AP, John I, Hennegan TD, Rohlfs M, Richard J, Iqbal M, Dett T, Lacey C, Jackson N, Rodgers T, Phillips S, Duncan S, Haydu L, Lin R, Amaria RN, Wong MK, Diab A, Yee C, Patel SP, McQuade JL, Fischer GM, McCutcheon IE, O'Brien BJ, Tummala S, Debnam M, Guha-Thakurta N, Wargo JA, Burton EM, Tawbi HA, Davies MA. Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results. Nat Med 29(4):898-905, 2023. e-Pub 2023. PMID: 36997799.
9. Ziyaee H, Cardenas CE, Yeboa DN, Li J, Ferguson SD, Johnson J, Zhou Z, Sanders J, Mumme R, Court L, Briere T, Yang J. Automated Brain Metastases Segmentation With a Deep Dive Into False-positive Detection. Adv Radiat Oncol 8(1):101085, 2023. e-Pub 2022. PMID: 36299565.
10. Karz A, Dimitrova M, Kleffman K, Alvarez-Breckenridge C, Atkins MB, Boire A, Bosenberg M, Brastianos P, Cahill DP, Chen Q, Ferguson S, Forsyth P, Glitza Oliva IC, Goldberg SB, Holmen SL, Knisely JPS, Merlino G, Nguyen DX, Pacold ME, Perez-Guijarro E, Smalley KSM, Tawbi HA, Wen PY, Davies MA, Kluger HM, Mehnert JM, Hernando E. Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities. Pigment Cell Melanoma Res. e-Pub 2022. PMID: 35912544.
11. Najem H, Ott M, Kassab C, Rao A, Rao G, Marisetty A, Sonabend AM, Horbinski C, Verhaak R, Shankar A, Krishnan SN, Varn FS, Arrieta VA, Gupta P, Ferguson SD, Huse JT, Fuller GN, Long JP, Winkowski DE, Freiberg BA, James CD, Platanias LC, Lesniak MS, Burks JK, Heimberger AB. Central nervous system immune interactome is function of cancer lineage, tumor microenvironment and STAT3 expression. JCI Insight 7(9), 2022. e-Pub 2022. PMID: 35316217.
12. Yeh MY, Chen HS, Hou P, Kumar VA, Johnson JM, Noll KR, Prabhu SS, Ferguson SD, Schomer DF, Peng HH, Liu HL. Cerebrovascular Reactivity Mapping Using Resting-State Functional MRI in Patients With Gliomas. J Magn Reson Imaging. e-Pub 2022. PMID: 35396789.
13. Shepard MJ, Haider AS, Prabhu SS, Sawaya R, DeMonte F, McCutcheon IE, Weinberg JS, Ferguson SD, Suki D, Fuller GN, Lang FF. Long term outcomes following surgery for pineal region tumors. J Neurooncol 156(3):491-498, 2022. e-Pub 2022. PMID: 35083579.
14. Ene CI, Ferguson SD. Surgical Management of Brain Metastasis: Challenges and Nuances. Front Oncol 12:847110, 2022. e-Pub 2022. PMID: 35359380.
15. Piña Y, Yadugiri S, Yeboa DN, Ferguson SD, Forsyth PA, Oliva ICG. Advances in Diagnosis and Treatment for Leptomeningeal Disease in Melanoma. Curr Oncol Rep 24(1):43-54, 2022. e-Pub 2022. PMID: 35059999.
16. Al-Holou WN, Suki D, Hodges TR, Everson RG, Freeman J, Ferguson SD, McCutcheon IE, Prabhu SS, Weinberg JS, Sawaya R, Lang FF. Circumferential sulcus-guided resection technique for improved outcomes of low-grade gliomas. J Neurosurg:1-11. e-Pub 2022. PMID: 34996044.
17. Muir M, Prinsloo S, Michener H, Traylor JI, Patel R, Gadot R, de Almeida Bastos DC, Kumar VA, Ferguson S, Prabhu SS. TMS Seeded Diffusion Tensor Imaging Tractography Predicts Permanent Neurological Deficits. Cancers (Basel) 14(2), 2022. e-Pub 2022. PMID: 35053503.
18. Aaroe AE, Glitza Oliva IC, Al-Zubidi N, Nader ME, Kaya D, Ferguson SD, Wang C, Fuller G, Harrison RA. Pearls & Oy-sters: Primary Pineal Melanoma With Leptomeningeal Carcinomatosis. Neurology. e-Pub 2021. PMID: 33931525.
19. Noll KR, Chen HS, Wefel JS, Kumar VA, Hou P, Ferguson SD, Rao G, Johnson JM, Schomer DF, Suki D, Prabhu SS, Liu HL. Alterations in Functional Connectomics Associated With Neurocognitive Changes Following Glioma Resection. Neurosurgery 88(3):544-551, 2021. e-Pub 2020. PMID: 33080024.
20. Ferguson SD, Hodges TR, Majd NK, Alfaro-Munoz K, Al-Holou WN, Suki D, de Groot JF, Fuller GN, Xue L, Li M, Jacobs C, Rao G, Colen RR, Xiu J, Verhaak R, Spetzler D, Khasraw M, Sawaya R, Long JP, Heimberger AB. A validated integrated clinical and molecular glioblastoma long-term survival-predictive nomogram. Neurooncol Adv 3(1):vdaa146, 2021. e-Pub 2020. PMID: 33426529.
21. Ferguson SD, Fomchenko EI, Guerrieri RA, Glitza Oliva IC. Challenges and Advances in Diagnosis and Treatment of Leptomeningeal Disease (LMD). Front Oncol 11:800053, 2021. e-Pub 2022. PMID: 35096602.
22. Giridharan N, Glitza Oliva IC, O'Brien BJ, Parker Kerrigan BC, Heimberger AB, Ferguson SD. Targeting the Tumor Microenvironment in Brain Metastasis. Neurosurg Clin N Am 31(4):641-649, 2020. PMID: 32921358.
23. Ott M, Tomaszowski KH, Marisetty A, Kong LY, Wei J, Duna M, Blumberg K, Ji X, Jacobs C, Fuller GN, Langford LA, Huse JT, Long JP, Hu J, Li S, Weinberg JS, Prabhu SS, Sawaya R, Ferguson S, Rao G, Lang FF, Curran MA, Heimberger AB. Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration. JCI Insight 5(17), 2020. e-Pub 2020. PMID: 32721947.
24. Kumar VA, Heiba IM, Prabhu SS, Chen MM, Colen RR, Young AL, Johnson JM, Hou P, Noll K, Ferguson SD, Rao G, Lang FF, Schomer DF, Liu HL. The role of resting-state functional MRI for clinical preoperative language mapping. Cancer Imaging 20(1):47, 2020. e-Pub 2020. PMID: 32653026.
25. Anakwenze CP, McGovern S, Taku N, Liao K, Boyce-Fappiano DR, Kamiya-Matsuoka C, Ghia A, Chung C, Trifiletti D, Ferguson SD, Li J, Yeboa DN. Association between Facility Volume and Overall Survival for Patients with Grade II Meningioma after Gross Total Resection. World Neurosurg. e-Pub 2020. PMID: 32407910.
26. de Groot J, Penas-Prado M, Alfaro-Munoz K, Hunter K, Pei BL, O'Brien B, Weathers SP, Loghin M, Kamiya Matsouka C, Yung WKA, Mandel J, Wu J, Yuan Y, Zhou S, Fuller GN, Huse J, Rao G, Weinberg JS, Prabhu SS, McCutcheon IE, Lang FF, Ferguson SD, Sawaya R, Colen R, Yadav SS, Blando J, Vence L, Allison J, Sharma P, Heimberger AB. Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages. Neuro Oncol 22(4):539-549, 2020. PMID: 31755915.
27. Haydu LE, Lo SN, McQuade JL, Amaria RN, Wargo J, Ross MI, Cormier JN, Lucci A, Lee JE, Ferguson SD, Saw RPM, Spillane AJ, Shannon KF, Stretch JR, Hwu P, Patel SP, Diab A, Wong MKK, Glitza Oliva IC, Tawbi H, Carlino MS, Menzies AM, Long GV, Lazar AJ, Tetzlaff MT, Scolyer RA, Gershenwald JE, Thompson JF, Davies MA. Cumulative Incidence and Predictors of CNS Metastasis for Patients With American Joint Committee on Cancer 8th Edition Stage III Melanoma. J Clin Oncol:JCO1901508. e-Pub 2020. PMID: 31990608.
28. Hsu AL, Chen HS, Hou P, Wu CW, Johnson JM, Noll KR, Prabhu SS, Ferguson SD, Kumar VA, Schomer DF, Chen JH, Liu HL. Presurgical resting-state functional MRI language mapping with seed selection guided by regional homogeneity. Magn Reson Med. e-Pub 2019. PMID: 31793025.
29. Ferguson SD, Bindal S, Bassett RL, Haydu LE, McCutcheon IE, Heimberger AB, Li J, O'Brien BJ, Guha-Thakurta N, Tetzlaff MT, Tawbi H, Davies MA, Glitza IC. Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD). J Neurooncol. e-Pub 2019. PMID: 30847840.
30. Al-Holou WN, Hodges TR, Everson RG, Freeman J, Zhou S, Suki D, Rao G, Ferguson SD, Heimberger AB, McCutcheon IE, Prabhu SS, Lang FF, Weinberg JS, Wildrick DM, Sawaya R. Perilesional Resection of Glioblastoma Is Independently Associated With Improved Outcomes. Neurosurgery. e-Pub 2019. PMID: 30799490.
31. Yeboa DN, Liao KP, Guadagnolo BA, Rao G, Bishop A, Chung C, Li J, Tatsui CE, Rhines LD, Ferguson S, Paulino AC, Ghia AJ. National Patterns of Care in the Management of WHO Grade II and III Spinal Ependymomas. World Neurosurg. e-Pub 2019. PMID: 30641236.
32. Ferguson SD, Zheng S, Xiu J, Zhou S, Khasraw M, Brastianos PK, Kesari S, Hu J, Rudnick J, Salacz ME, Piccioni D, Huang S, Davies MA, Glitza IC, Heymach JV, Zhang J, Ibrahim NK, DeGroot JF, McCarty J, O'Brien BJ, Sawaya R, Verhaak RGW, Reddy SK, Priebe W, Gatalica Z, Spetzler D, Heimberger AB. Profiles of Brain Metastases: Prioritization of Therapeutic Targets. Int J Cancer. e-Pub 2018. PMID: 29923182.
33. Ferguson SD, Zhou S, Huse JT, de Groot JF, Xiu J, Subramaniam DS, Mehta S, Gatalica Z, Swensen J, Sanai N, Spetzler D, Heimberger AB. Targetable Gene Fusions Associate With the IDH Wild-Type Astrocytic Lineage in Adult Gliomas. J Neuropathol Exp Neurol 77(6):437-442, 2018. PMID: 29718398.
34. Zhang Z, Yang J, Ho A, Jiang W, Logan J, Wang X, Brown PD, McGovern SL, Guha-Thakurta N, Ferguson SD, Fave X, Zhang L, Mackin D, Court LE, Li J. A predictive model for distinguishing radiation necrosis from tumour progression after gamma knife radiosurgery based on radiomic features from MR images. Eur Radiol 28(6):2255-2263, 2018. e-Pub 2017. PMID: 29178031.
35. Zhang Z, Yang J, Ho A, Jiang W, Logan J, Wang X, Brown PD, McGovern SL, Guha-Thakurta N, Ferguson SD, Fave X, Zhang L, Mackin D, Court LE, Li J. Correction to: A predictive model for distinguishing radiation necrosis from tumour progression after gamma knife radiosurgery based on radiomic features from MR images. Eur Radiol. e-Pub 2018. PMID: 29541912.
36. Ferguson SD, Levine NB, Suki D, Tsung AJ, Lang FF, Sawaya R, Weinberg JS, McCutcheon IE. The surgical treatment of tumors of the fourth ventricle: a single-institution experience. J Neurosurg 128(2):1-13, 2018. e-Pub 2017. PMID: 28409732.
37. Hsu AL, Hou P, Johnson JM, Wu CW, Noll KR, Prabhu SS, Ferguson SD, Kumar VA, Schomer DF, Hazle JD, Chen JH, Liu HL. IClinfMRI Software for Integrating Functional MRI Techniques in Presurgical Mapping and Clinical Studies. Front Neuroinform 12:11, 2018. e-Pub 2018. PMID: 29593520.
38. Ferguson SD, Zhou S, Xiu J, Hashimoto Y, Sanai N, Kim L, Kesari S, de Groot J, Spetzler D, Heimberger AB. Ependymomas overexpress chemoresistance and DNA repair-related proteins. Oncotarget 9(8):7822-7831, 2018. e-Pub 2017. PMID: 29487694.
39. Ferguson SD, Wagner KM, Prabhu SS, McAleer MF, McCutcheon IE, Sawaya R. Neurosurgical management of brain metastases. Clin Exp Metastasis 34(6-7):377-389, 2017. e-Pub 2017. PMID: 28965270.
40. Mahajan A, Ahmed S, McAleer MF, Weinberg JS, Li J, Brown P, Settle S, Prabhu SS, Lang FF, Levine N, McGovern S, Sulman E, McCutcheon IE, Azeem S, Cahill D, Tatsui C, Heimberger AB, Ferguson S, Ghia A, Demonte F, Raza S, Guha-Thakurta N, Yang J, Sawaya R, Hess KR, Rao G. Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial. Lancet Oncol. e-Pub 2017. PMID: 28687375.
41. Glitza IC, Ferguson SD, Guha-Thakurta N. Rapid resolution of leptomeningeal disease with targeted therapy in a metastatic melanoma patient. J Neurooncol. e-Pub 2017. PMID: 28528423.
42. Mahajan A, Ahmed S, Li J, McAleer MF, Weinberg J, Brown PD, Prabhu S, Lang FF, McGovern SL, McCutcheon IE, Heimberger A, Sulman EP, Ghia AJ, Ferguson S, Hess K, Rao G. Postoperative Stereotactic Radiosurgery Versus Observation for Completely Resected Brain Metastases: Results of a Prospective Randomized Study. Int J Radiat Oncol Biol Phys 96(2S):S2, 2016. PMID: 27675774.
43. Ferguson SD, Xiu J, Weathers SP, Zhou S, Kesari S, Weiss SE, Verhaak RG, Hohl RJ, Barger GR, Reddy SK, Heimberger AB. GBM-associated mutations and altered protein expression are more common in young patients. Oncotarget. e-Pub 2016. PMID: 27579614.
44. Ho JC, Luo D, Guha-Thakurta N, Ferguson SD, Ghia AJ, Yang JN, Brown PD, Voong KR. Gamma Knife Stereotactic Radiosurgery for Brain Metastases Using Only 3 Pins. Neurosurgery 78(6):877-82, 2016. e-Pub 2015. PMID: 26488329.
45. Hodges TR, Ferguson SD, Caruso HG, Kohanbash G, Zhou S, Cloughesy TF, Berger MS, Poste GH, Khasraw M, Ba S, Jiang T, Mikkelson T, Yung WK, de Groot JF, Fine H, Cantley LC, Mellinghoff IK, Mitchell DA, Okada H, Heimberger AB. Prioritization schema for immunotherapy clinical trials in glioblastoma. Oncoimmunology 5(6):e1145332, 2016. e-Pub 2016. PMID: 27471611.
46. Pan IW, Ferguson SD, Lam S. Patient and treatment factors associated with survival among adult glioblastoma patients: A USA population-based study from 2000-2010. J Clin Neurosci. e-Pub 2015. PMID: 26122381.
47. Ferguson SD, Waguespack SG, Langford LA, Ater JL, McCutcheon IE. Fatal Juvenile Xanthogranuloma presenting as a sellar lesion. Case report and literature review. Childs Nerv Syst 31(5):777-84, 2015. e-Pub 2014. PMID: 25503249.
48. Balyasnikova IV, Prasol MS, Ferguson SD, Han Y, Ahmed AU, Gutova M, Tobias AL, Mustafi D, Rincón E, Zhang L, Aboody KS, Lesniak MS. Intranasal delivery of mesenchymal stem cells significantly extends survival of irradiated mice with experimental brain tumors. Mol Ther 22(1):140-8, 2014. e-Pub 2013. PMID: 24002694.
49. Wei J, Wang F, Kong LY, Xu S, Doucette T, Ferguson SD, Yang Y, McEnery K, Jethwa K, Gjyshi O, Qiao W, Levine NB, Lang FF, Rao G, Fuller GN, Calin GA, Heimberger AB. miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma. Cancer Res 73(13):3913-26, 2013. e-Pub 2013. PMID: 23636127.
50. Thaci B, Ulasov IV, Ahmed AU, Ferguson SD, Han Y, Lesniak MS. Anti-angiogenic therapy increases intratumoral adenovirus distribution by inducing collagen degradation. Gene Ther 20(3):318-27, 2013. e-Pub 2012. PMID: 22673390.
51. Doucette TA, Kong LY, Yang Y, Ferguson SD, Yang J, Wei J, Qiao W, Fuller GN, Bhat KP, Aldape K, Priebe W, Bögler O, Heimberger AB, Rao G. Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma. Neuro Oncol 14(9):1136-45, 2012. e-Pub 2012. PMID: 22753228.
52. Lee I, Fox PS, Ferguson SD, Bassett R, Kong LY, Schacherer CW, Gershenwald JE, Grimm EA, Fuller GN, Heimberger AB. The expression of p-STAT3 in stage IV melanoma: risk of CNS metastasis and survival. Oncotarget 3(3):336-44, 2012. PMID: 22488042.
53. Balyasnikova IV, Ferguson SD, Han Y, Liu F, Lesniak MS. Therapeutic effect of neural stem cells expressing TRAIL and bortezomib in mice with glioma xenografts. Cancer Lett 310(2):148-59, 2011. e-Pub 2011. PMID: 21802840.
54. Ferguson SD, Musleh W, Gurbuxani S, Shafizadeh SF, Lesniak MS. Intracranial mucosa-associated lymphoid tissue (MALT) lymphoma. J Clin Neurosci 17(5):666-9, 2010. e-Pub 2010. PMID: 20202849.
55. Ferguson SD, Rosen DS, Bardo D, MacDonald RL. Arterial Diameters on Catheter and Computed Tomographic Angiography. World Neurosurg 73(3):165-73, 2010.
56. Balyasnikova IV, Ferguson SD, Sengupta S, Han Y, Lesniak MS. Mesenchymal stem cells modified with a single-chain antibody against EGFRvIII successfully inhibit the growth of human xenograft malignant glioma. PLoS One 5(3):e9750, 2010. e-Pub 2010. PMID: 20305783.
57. Ferguson SD, Coccaro EF. History of mild to moderate traumatic brain injury and aggression in physically healthy participants with and without personality disorder. J Pers Disord 23(3):230-9, 2009. PMID: 19538079.
58. Rosen DS, Ferguson SD, Ogden AT, Huo D, Fessler RG. Obesity and self-reported outcome after minimally invasive lumbar spinal fusion surgery. Neurosurgery 63(5):956-60; discussion 960, 2008. PMID: 19005386.
59. Ferguson SD, Macdonald RL. Predictors of cerebral infarction in patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 60(4):658-67; discussion 667, 2007. PMID: 17415202.
60. Ferguson SD, Michael N, Frim DM. Observations regarding failure of cerebrospinal fluid shunts early after implantation. Neurosurg Focus 22(4):E7, 2007. e-Pub 2007. PMID: 17613196.
61. Fagan LH, Ferguson S, Yassari R, Frim DM. The Chiari pseudotumor cerebri syndrome: symptom recurrence after decompressive surgery for Chiari malformation type I. Pediatr Neurosurg 42(1):14-9, 2006. PMID: 16357496.
62. Ferguson S, Lesniak MS. Percival Bailey and the classification of brain tumors. Neurosurg Focus 18(4):e7, 2005. e-Pub 2005. PMID: 15844870.
63. Palmer SC, Coyne JC, Ferguson S,. Validity of Horowitz's Impact of Events Scale as a Screen for PTSD in a Sample of Breast Cancer Patients. Annals of Behavioral Medicine 24, 2002. e-Pub 2002.

Invited Articles

1. Ferguson SD, McCutcheon IE. Surgical Management of Gliomas in Eloquent Cortex. Prog Neurol Surg 30:159-172, 2018. e-Pub 2017. PMID: 29241173.
2. Ferguson SD, Momin EN, Weinberg JS. Surgical Management of Recurrent Intracranial Gliomas. Prog Neurol Surg 30:218-231, 2018. e-Pub 2017. PMID: 29241177.
3. Srinivasan VM, Ferguson SD, Lee S, Weathers SP, Kerrigan BCP, Heimberger AB. Tumor Vaccines for Malignant Gliomas. Neurotherapeutics 14(2):345-357, 2017. PMID: 28389997.
4. Hodges TR, Ferguson SD, Heimberger AB. Immunotherapy in glioblastoma: emerging options in precision medicine. CNS Oncol 5(3):175-86, 2016. e-Pub 2016. PMID: 27225028.
5. Ferguson SD, Srinivasan VM, Ghali MG, Heimberger AB. Cytomegalovirus-targeted immunotherapy and glioblastoma: hype or hope?. Immunotherapy 8(4):413-23, 2016. PMID: 26973123.
6. Ferguson SD, Srinivasan VM, Heimberger AB. The role of STAT3 in tumor-mediated immune suppression. J Neurooncol 123(3):385-94, 2015. e-Pub 2015. PMID: 25700834.
7. Ferguson SD. Malignant Gliomas: Diagnosis and Treatment. Dis Mon 57(10):558-69, 2011.
8. Ferguson SD, Ahmed AU, Thaci B, Mercer RW, Lesniak MS. Crossing the Boundaries: Stem Cells and Gene Therapy. Discov Medicine 9(46):192-6, 2011.
9. Ferguson SD, Foster K, Yamini B. Convection-Enhanced Delivery for Treatment of Brain Tumors. Expert Review Anticancer Therapy 7:79-85, 2007.
10. Ferguson S, Lesniak MS. Convection enhanced Drug Delivery of Novel Therapeutic Agents to Malignant Brain Tumors. Current Drug Delivery 4(2):169-80, 2007.

Abstracts

1. Hsu AL, Hou P, Johnson JM, Wu CW, Noll KR, Prabhu SS, Ferguson SD, Kumar VA, Schomer DF, Hazle JD, Chen JH, Liu HL. A software package designed to integrate advanced fMRI methods for presurgical mapping and clinical studies (IClinfMRI). Joint Annual Meeting ISMRM-ESMRMB, 2018.
2. Abrol S, Kotrotsou A, Hassan A, Elfshafeey N, Idris T, Manohar N, Agarwal A, Hassan I, Salek K, Farid N, McDonald C, Weathers SP, Bahrami N, Bergamaschi S, Elakkad A, Alfaro-Munoz K, Moron F, Huse J, Weinberg J, Ferguson S, Kogias E, Heimberger A, Sawaya R, Kumar A, deGroot J, Law M, Zinn P, Colen R. Radiomics discriminates pseudo-progression from true progression in glioblastoma patients: A large-scale multi-institutional study. Cancer Imaging and Intervention Conference, The University of Texas MD Anderson Cancer Center, 2018.
3. Ferguson S, Zheng S, Xiu J, Zhou S, Khasraw M, Brastianos PK, Kesari S, Hu J, Rudnick J, Salacz M, Piccioni D, Suyun H, Davies M, Glitza I, Heymach J, Zhang J, Ibrahim N, de Groot J, McCarty J, O'Brien BJ, Sawaya R, Verhaak R, Reddy S, Priebe W, Spetzler D, Heimberger A. Pan-Cancer Profiles of Brain Metastases: Prioritization of Therapeutic Targets. 22nd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology, 2017.
4. Glitza IC, Ma J, Ferguson SD, Bassett Jr RL, Haydu L, Davies MA. Characteristics of metastatic melanoma (MM) patients with leptomeningeal disease (LMD) and survival of > 1 year. ESMO European Society for Medical Oncology, 2017.
5. Wang X, Li Jing, McAleer MF, McGovern SL, Ghia AJ, Sulman EP, Brown PD, Lang FF Jr, Ferguson SD, McCutcheon IE, Prabhu SS, Heimberger AB, Weinberg J, Sawaya R, Ahmed S, Luo D, Rao G, Mahajan A. Pattern of Failure after Resection Followed by Gamma Knife Radiosurgery to the Surgical Cavity. 13th Congress of the International Stereotactic Radiosurgery Society, 2017.
6. Bindal S, Ferguson SD, Davies MA, Haydu L, Bassett RL Jr, McCutcheon IE, Glitza IC. Leptomeningeal disease (LMD) from metastatic melanoma: a single institution experience and predictors of survival. 2016 Society for Melanoma Research Congress, 2016.
7. Xiu J, Ferguson SD, Reddy SK, Kesari S, Weiss SE, Hohl RJ, Barger G, Heimberger AB. Comparison of molecular alteration in glioblastoma tumors from old and young patients. American Society of Clinical Oncology (ASCO), 2016.
8. Osborne E, Ferguson S, Guha-Thakutra N, Brown P, McAleer MF. Gamma Knife stereotactic radiosurgery for solitary brain metastses with baseline edema: feasibility and outcomes. 18th Leksell Gamma Knife Society, 2016.
9. Zhongxiang Z, Phan J, Yang JN, Fang P, Guha-Thakurta N, Frances M. Tumor Control of Peripherally Located Single Brain Metastases. The International Leksell Gamma Knife Society Meeting 2016, 2016.
10. Ho JC, Luo D, Guha-Thakurta N, Ferguson SD, Ghia AJ, Yang JN, Brown PD, Voong KR. Gamma Knife Stereotactic Radiosurgery for Brain Metastases Using Only 3 Pins. Society for NeuroOncology Annual Meeting, 2015.
11. Balyasnikova IV, Ferguson SD, Prasol MS, Ahmed, AU, Yu Han, Lesniak MS. The therapeutic basis of intranasal stem cell delivery for the treatment of glioblastoma. Society for Neuro-Oncology, 2012.
12. Kong LY, Doucette T, Ferguson SD, Hachem J, Yang Y, Wei1 J, Priebe W, Fuller GN, Qiao W, Rao G, Heimberger AB. Chemotherapeutic modulation of the glioma development and invasion in vivo. Society for Neuro-Oncology Annual Meeting, 2012.

Book Chapters

1. Ferguson SD, McCutcheon IE. Meningitis and Encephalitis. In: Youmans & Winn Neurological Surgery. Seventh. Elsevier: Philadelphia, 352, 2017.
2. Ferguson SD, McCutcheon IE. Pituitary Tumors. In: UICC Manual of Clinical Oncology. Ninth. John Wiley & Sons, 609-625, 2015.
3. Ferguson SD, LaRiviere MJ, Mansour N, Lesniak MS. Malignant Glioma: Chemovirotherapy. In: Tumors of the Central Nervous System. First. Springer, 357-364, 2011.